|
Index of reports
> Cases with Thrombocytopenia (14)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rituxan (Rituximab) where reactions include thrombocytopenia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Rituxan side effects in 81 year old male
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-08-22
Patient: 81 year old male
Reactions: Vision Blurred, Neutropenia, Thrombocytopenia, Fall, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15
Patient: male, weighing 91.7 kg (201.7 pounds)
Reactions: Pneumonia, Anaemia, Pancytopenia, Febrile Neutropenia, Respiratory Failure, Muscle Abscess, Thrombocytopenia, Cardiac Arrest
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Rituxan
Dosage: 150 milligram
Start date: 2012-05-14
Vidaza
Dosage: 150 milligram
Start date: 2012-05-14
Rituxan
Start date: 2012-06-22
Vidaza
Dosage: 150 milligram
Start date: 2012-07-19
End date: 2012-07-20
Rituxan
Start date: 2012-07-19
End date: 2012-07-20
Rituxan
Dosage: 17.8571 milligram
Start date: 2012-08-04
Other drugs received by patient: Procrit; Fluticasone Propionate; Folic Acid; Hydrocortisone-Pramoxine; Metoprolol Tartrate; Rosuvastatin; Meropenem; Vancomycin; Dextrose; Acetaminophen; Calcium + Vitamin D; Ciprofloxacin-Dexamethasone Otic; Diphenhydramine Hydrochloride; Filgrastim; Multi-Vitamins; Phenylephrine Hydrochloride; Acetaminophen; Naproxen; Whole Blood; Prednisone TAB; Vitamin B-12; Acetaminophen; Benazepril Hydrochloride; Augmentin '500'; Amlodipine; Omeprazole; Sodium Chloride
Possible Rituxan side effects in female
Reported by a physician from United States on 2012-07-06
Patient: female, weighing 90.8 kg (199.8 pounds)
Reactions: Platelet Count Decreased, Thrombocytopenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituxan
Dosage: 1000 mg once
Indication: Rheumatoid Arthritis
Start date: 2012-05-02
End date: 2012-05-02
Rituxan
Dosage: 1000 mg once
Start date: 2012-05-16
End date: 2012-05-16
Other drugs received by patient: Citalopram Hydrobromide; Prednisone; Wellbutrin; Methotrexate; Lisinopril; Prednisone
Possible Rituxan side effects in female
Reported by a physician from Germany on 2012-07-06
Patient: female
Reactions: Presyncope, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituxan
Dosage: 742.5 mg, q2wk
Indication: B-Cell Lymphoma
Start date: 2012-04-25
Prednisolone
Dosage: 100 mg, q2wk
Indication: B-Cell Lymphoma
Start date: 2012-04-26
End date: 2012-04-30
Cyclophosphamide
Dosage: 1483 mg, q2wk
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Doxorubicin HCL
Dosage: 100 mg, q2wk
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-04-29
Vincristine
Dosage: 3.94 mg, q2wk
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Other drugs received by patient: Ramipril; Nebivolol; Tiotropium Bromide; Levothyroxine Sodium; Trimethoprim + Sulfamethoxazole; Acyclovir; Simvastatin; Torsemide; Acetylsalicylic Acid SRT; Enoxaparin Sodium; Pantoprazole
Possible Rituxan side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-10
Patient: 54 year old male, weighing 91.9 kg (202.2 pounds)
Reactions: Asthma, Dyspnoea, Neutropenia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 20 milligram
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2012-04-25
Revlimid
Dosage: 20 milligram
Administration route: Oral
Start date: 2011-08-17
Rituxan
Dosage: 375 milligram/sq. meter
Indication: non-Hodgkin's Lymphoma
Start date: 2012-04-25
Revlimid
Dosage: 15 milligram
Administration route: Oral
Other drugs received by patient: Potassium Chloride; Simvastatin; Altace; Zofran; Albuterol; Acidophilus; Zocor; Glucosamine; Insulin; Ultram; Tramadol Hydrochloride; Aspirin; Ciprofloxacin; Hydrochlorothiazide; Ondansetron; Visine EYE Drops; Calcium + Vitamin D; Ondansetron; Ramipril; Humalog; Tessalon; Steroid; Toradol; Singulair; Multi-Vitamins; Novolog; Steroid
Possible Rituxan side effects in female
Reported by a consumer/non-health professional from United States on 2012-05-02
Patient: female
Reactions: Vomiting, Nausea, Anaemia, Constipation, Death, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in 63 year old female
Reported by a pharmacist from Canada on 2012-04-10
Patient: 63 year old female
Reactions: Pneumocystis Jiroveci Pneumonia, Respiratory Failure, Neutropenia, Cognitive Disorder, Thrombocytopenia, Leukopenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Rituxan
Dosage: (the patient received rituximab on 13 january 2012).
Start date: 2011-12-30
Rituxan
Dosage: (the patient received rituximab on 21 july 2011, 25 july 2011 and 27 july 2011).
Indication: Epstein-Barr Virus Infection
Start date: 2011-07-19
Other drugs received by patient: Proctosone; Cefazolin; Ceftazidime; Albuterol; Primaquine; Levofloxacin; Lansoprazole; Piperacillin and Tazobactam; Nabilone; Prednisone TAB; Hydromorphone HCL; Ipratropium Bromide; Clindamycin; Nystatin; Solu-Medrol
Possible Rituxan side effects in male
Reported by a pharmacist from Canada on 2012-03-12
Patient: male
Reactions: Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituxan
Indication: Anaemia Haemolytic Autoimmune
Danazol
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Calcium; Levothyroxine Sodium; Folic Acid; Advair Diskus 100 / 50; Diltiazem; Furosemide; Nitroglycerin; Prednisone; Naproxen; Vitamin B-12; Actonel; Ventolin; Perindopril Erbumine; Lipitor; Rabeprazole Sodium; Aspirin; Spiriva
Possible Rituxan side effects in
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-02-27
Patient:
Reactions: Death, Anaemia, Thrombocytopenia, Leukopenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Rituxan
Indication: Diffuse Large B-Cell Lymphoma
Possible Rituxan side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-21
Patient: male, weighing 101.0 kg (222.2 pounds)
Reactions: Pseudomonas Infection, Pyrexia, Blood Sodium Abnormal, Systolic Dysfunction, Blood Phosphorus Decreased, Hypocalcaemia, Thrombocytopenia, Blood Creatinine Increased, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: Burkitt's Lymphoma
Start date: 2009-01-28
End date: 2009-04-12
Cyclophosphamide
End date: 2009-04-12
Cytarabine
Indication: Burkitt's Lymphoma
Start date: 2009-01-30
Cyclophosphamide
Dosage: days 2-5
Start date: 2009-01-29
End date: 2009-02-01
Ifosfamide
Indication: Burkitt's Lymphoma
Start date: 2009-01-28
End date: 2009-04-12
Rituxan
Start date: 2009-01-28
Cyclophosphamide
Indication: Burkitt's Lymphoma
Start date: 2009-01-28
Methotrexate
Indication: Burkitt's Lymphoma
Start date: 2009-02-06
Rituxan
Start date: 2009-01-26
Cytarabine
Start date: 2009-01-28
Rituxan
End date: 2009-04-12
Methotrexate
End date: 2009-04-12
Doxorubicin HCL
Dosage: cycles 1-6
Cytarabine
End date: 2009-04-12
Filgrastim
Indication: Burkitt's Lymphoma
Start date: 2009-01-28
End date: 2009-04-12
Etoposide
Indication: Burkitt's Lymphoma
Start date: 2009-01-28
End date: 2009-04-12
Rituxan
Indication: Burkitt's Lymphoma
Start date: 2009-02-04
Vincristine
Indication: Burkitt's Lymphoma
Start date: 2009-01-28
End date: 2009-04-12
Methotrexate
Start date: 2009-01-28
Leucovorin Calcium
Indication: Burkitt's Lymphoma
Start date: 2009-01-28
End date: 2009-04-12
Possible Rituxan side effects in female
Reported by a physician from United States on 2011-12-20
Patient: female, weighing 60.3 kg (132.7 pounds)
Reactions: Stomatitis, Neutrophil Count, Oral Infection, Lymphopenia, Febrile Neutropenia, Transaminases Increased, Lymphocyte Count, Aspartate Aminotransferase Increased, Hypocalcaemia, Thrombocytopenia, Candidiasis, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituxan
Dosage: 820 mg
Start date: 2009-10-12
Leucovorin Calcium
Indication: Burkitt's Lymphoma Stage IV
Rituxan
Start date: 2009-11-30
Cyclophosphamide
Dosage: 328mg
Start date: 2009-10-14
End date: 2009-10-17
Vincristine
Methotrexate
Dosage: 4918mg
Indication: Burkitt's Lymphoma Stage IV
Start date: 2009-10-22
Methotrexate
Start date: 2009-08-26
Ifosfamide
Indication: Burkitt's Lymphoma Stage IV
End date: 2009-11-30
Ifosfamide
Ifosfamide
Ifosfamide
Start date: 2009-08-14
Etoposide
End date: 2009-11-30
Filgrastim
Filgrastim
Rituxan
Dosage: 825 mg
Indication: Burkitt's Lymphoma Stage IV
Start date: 2009-08-14
Cytarabine
Leucovorin Calcium
Start date: 2009-08-14
Filgrastim
Indication: Burkitt's Lymphoma Stage IV
End date: 2009-11-30
Doxorubicin HCL
Dosage: 66 mg
Indication: Burkitt's Lymphoma Stage IV
Start date: 2009-08-14
Etoposide
Indication: Burkitt's Lymphoma Stage IV
Doxorubicin HCL
End date: 2009-11-30
Rituxan
Dosage: 825 mg
Start date: 2009-08-24
Cyclophosphamide
Dosage: 1312mg
Indication: Burkitt's Lymphoma Stage IV
Start date: 2009-10-13
Methotrexate
End date: 2009-11-30
Etoposide
Doxorubicin HCL
Cyclophosphamide
Start date: 2009-08-16
End date: 2009-08-19
Vincristine
Dosage: 2mg
Indication: Burkitt's Lymphoma Stage IV
Start date: 2009-10-13
Vincristine
Dosage: 2mg
Start date: 2009-08-14
Vincristine
End date: 2009-11-30
Cytarabine
Indication: Burkitt's Lymphoma Stage IV
End date: 2009-11-30
Cytarabine
Etoposide
Start date: 2009-08-14
Filgrastim
Start date: 2009-08-14
Doxorubicin HCL
Dosage: 49mg, cycle 3
Start date: 2009-10-13
Rituxan
Dosage: 820 mg
Start date: 2009-10-20
Cyclophosphamide
Dosage: 1320mg
Start date: 2009-08-14
Cyclophosphamide
End date: 2009-11-30
Cytarabine
Start date: 2009-08-15
Leucovorin Calcium
Methotrexate
Dosage: 500 mg
Start date: 2009-08-14
Leucovorin Calcium
End date: 2009-11-30
Other drugs received by patient: Benadryl; Sodium Chloride; Colace; Colace; Nystatin; Dextrose; Acetaminophen; Piperacillin; Lisinopril; Tazobactam; Allopurinol; Acyclovir; Fluconazole; Sodium Bicarbonate; Vancomycin Hychloride; Dapsone
Possible Rituxan side effects in female
Reported by a physician from Canada on 2011-12-08
Patient: female
Reactions: Pulmonary Embolism, Thrombocytopenia
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in
Reported by a physician from United States on 2011-10-26
Patient:
Reactions: Thrombocytopenia
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Velcade
Indication: Diffuse Large B-Cell Lymphoma
Rituxan
Indication: Diffuse Large B-Cell Lymphoma
Possible Rituxan side effects in
Reported by a physician from United States on 2011-10-14
Patient:
Reactions: Thrombocytopenia
Drug(s) suspected as cause:
Velcade
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Rituxan
Indication: Diffuse Large B-Cell Lymphoma
|
